Haemophilus influenzae type b vaccine (Hib vaccine) is a conjugate vaccine developed for the prevention of invasive disease caused by Haemophilus influenzae type b bacteria.

Due to routine use of the Hib vaccine in the U.S. since 1990, the incidence of invasive Hib disease has decreased to 1.3/100,000 children.^{[citation needed]}

Vaccinations against Haemophilus influenzae (Hib) have decreased early childhood meningitis significantly in developed countries^{[citation needed]}.

References

See also

• Conjugate vaccine
• Epiglottis
• Haemophilus influenzae